Skip to content

Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm

Comparison of Coventional Endoscopic Submucosal Dissection and Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01944540
Enrollment
70
Registered
2013-09-17
Start date
2013-08-31
Completion date
Unknown
Last updated
2013-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Brief summary

This study is aimed to analyze the outcomes after conventional endoscopic submucosal dissection (ESD) and optimized ESD with snaring (oESD-S) for colorectal neoplasm that is more than 20 mm in diameter of laterllay spreading tumor or flat elevated lesion without stalk. Optimized ESD with snaring means submucosal dissection followed by snaring when narrowed circumference of the remained submucosal tissue beneath the lesion is less than 5 mm in diameter with snaring, then resected by using an electric current. The investigators expect optimized ESD with snaring can provide more time-saving procedure with comparable en-bloc resection rate and perforation rate, when compared with the conventional ESD method.

Interventions

PROCEDUREOptimized ESD with snaring

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* colorectal laterally spreading tumor that is more than 20 mm in diameter * other elevated or flat colorectal neoplasm without stalk, that is more than 20 mm in diameter

Exclusion criteria

* colorectal neoplasms that are proven or suspected to be invaded more than submucosal invasion * colorectal neoplasms that have severe fibrosis beneath the target lesion * patient's refusal to participate this study * less than 18 years old * subjects who cannot consent voluntarily due to the communication difficulty

Design outcomes

Primary

MeasureTime frame
En Bloc resection rate8 months
procedure time8 months

Secondary

MeasureTime frameDescription
histologic complete resection rate8 months
complication rate8 monthsperforation rate, bleeding rate

Countries

South Korea

Contacts

Primary ContactJeong-Sik Byeon, MD
jsbyeon@amc.seoul.kr+82-2-3010-3905

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026